Trials / Completed
CompletedNCT00621218
A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea
A Pilot Study to Compare Tretinoin Gel, 0.05% to Tretinoin Gel Vehicle When Dosed Once or Twice Daily in Female Subjects With Classical Rosacea
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Coria Laboratories, Ltd. · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy and safety of tretinoin gel 0.05% to its vehicle when dosed once or twice daily in female subjects with rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tretinoin gel 0.05% | Apply tretinoin gel, 0.05% topically once or twice daily to female subjects with rosacea |
| DRUG | vehicle | Apply Atralin Gel vehicle topically once or twice daily to female subjects with rosacea. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-04-01
- Completion
- 2008-12-01
- First posted
- 2008-02-22
- Last updated
- 2008-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00621218. Inclusion in this directory is not an endorsement.